Abstract
1/2007
vol. 10
Does erythropoietin treatment of anaemia in chronic renal failure protect the heart?
Przew Lek 2007; 1: 34-40
Online publish date: 2007/03/05
Anaemia, due to lack of erythropoietin, is a serious complication in patients with chronic kidney disease (CKD). It is known that anaemia is an independent risk factor of mortality in over 60% of patients caused by cardiovascular complications in CKD. Erythropoietin treatment has a beneficial effect on the function and heart structure and prevents progressive development of cardiovascular complications in CKD patients.
Keywords
chronic kidney disease, anaemia, erythropoietin treatment
Integrated with
